Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate
Clinical trial NCT01209299 · COMPLETED
Trial details
- NCT number
- NCT01209299
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-01-19
- Primary completion
- 2012-02-19
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.